TT  Yale University

https://ocr.yale.edu/





     Office Locations:

433 Temple Street
New Haven, CT 06511
Phone: 203-436-8096
Fax: 203-436-8086

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Seed


 

Industries:

  • Energy & Clean Tech
  • Life Sciences & Healthcare
  • Medical Device
  • Software & Internet

  •  

    Description:

    The Yale University Office of Cooperative Research (OCR) was founded in 1982 and charged with extending and expanding Yale University's interaction with the private sector. The duties of the OCR include oversight for patenting and licensing activities, university inventions, and contractual relationships between faculty and industry. OCR staff work with Yale researchers to identify inventions that may ultimately become commercial products and services useful to the public. OCR staff also engage in industrial partnerships to license Yale inventions. The Office of Cooperative Research helps launch several new ventures every year. OCR is currently investing through the Blavatnik Fund. The Blavatnik Fund for Innovation bridges the gap between innovative, early-stage life science research and successful development of high-impact biomedical products. Pilot grants are eligible for up to $100,000 and development grants are eligible for up to $300,000.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Bill Wiesler Director of New Ventures
    Christopher Unsworth Associate Director
    David A. Lewin Senior Associate Director
    Hong Peng Associate Director
    James G. Boyle Executive Director

     

    Portfolio companies include:

     

    Recent News: